Clinical genitourinary cancerHumansMaleDocetaxelNitrilesProstatic Neoplasms
Association of Fat and Muscle Mass With Overall Survival in Patients With Metastatic Prostate Cancer Treated With Enzalutamide, Abiraterone, and Docetaxel.
İhsan Solmaz, Halil Kömek, Fethullah Kayan, Canan Can, İhsan Kaplan, Rıdvan Kiliç, Yunus Güzel, Mehmet Serdar Yildirim, Ömer Faruk Alakuş, Bilgin Bahadır Başgöz, Mehmet Özel, Eşref Araç
Published: 202610.1016/j.clgc.2025.102482
Abstract
OBJECTIVE: To investigate the association between fat and muscle mass parameters and overall survival in patients with castration-resistant metastatic prostate cancer (mCRPC) receiving chemotherapy or androgen deprivation therapy. MATERIALS AND METHO…
Preview only. Read the full abstract at the source